Antimicrobial Agents Practice Questions

Q: What is a known side effect of clofazimine?

Reddish black skin discoloration. ***Reddish black skin discoloration*** - **Clofazimine** is known to cause a dose-dependent and reversible **reddish-brown to black discoloration** of the skin, conjunctiva, and bodily secretions [1]. - This skin discoloration is a common and characteristic side effect associated with the drug's accumulation in fatty tissues and macrophages. *Hemolytic anaemia* - **Hemolytic anemia** is more commonly associated with drugs like **dapsone**, especially in patients with G6PD deficiency, or rifampicin in rare cases [1], [2]. - It is not a typical or well-known side effect of clofazimine. *Flu like syndrome* - **Flu-like syndrome** is a classic side effect associated with **rifampicin**, another drug used in the treatment of leprosy [2]. - This adverse effect is not characteristic of clofazimine. *Axillary freckling* - **Axillary freckling** (Crowe's sign) is a cutaneous manifestation associated with **neurofibromatosis type 1 (NF1)**. - It is a genetic condition and not a side effect of any medication.

Q: Which of the following causes retinal pigmentation?

Chloroquine. ***Chloroquine*** - Chloroquine can cause **retinal toxicity**, leading to **pigmentary changes** and potentially irreversible vision loss, particularly with prolonged use or high doses. - The characteristic finding is often described as **"bull's eye maculopathy,"** a central area of depigmentation surrounded by a ring of hyperpigmentation in the macula. *Quinine* - Quinine is known for causing **cinchonism**, which includes symptoms like **tinnitus**, headache, and blurred vision, but not typically retinal pigmentation. - While it can cause **visual disturbances**, these are usually related to **optic nerve toxicity** or vascular changes, not direct pigmentary retinopathy. *Mefloquine* - Mefloquine is associated with **neuropsychiatric side effects**, such as vivid dreams, anxiety, depression, and hallucinations, but not retinal pigmentation. - Its adverse ocular effects are less common than with chloroquine and do not typically involve permanent pigmentary changes to the retina. *Atovaquone* - Atovaquone is generally well-tolerated with common side effects including gastrointestinal upset, headache, and rash. - It is **not known to cause retinal pigmentation** or significant ocular toxicity.

Q: Which of the following statements about the primary clinical use of levamisole is true?

It is used against ascariasis and ancyclostomiasis. ***It is used against ascariasis and ancyclostomiasis*** - **Levamisole** is an **anthelmintic drug** primarily used for the treatment of **nematode infections**, specifically **roundworms (Ascaris lumbricoides)** and **hookworms (Ancylostoma duodenale)**. - It works by **paralyzing the worms**, leading to their expulsion in the feces. *It is the levoisomer of tetramisole* - While it is true that **levamisole** is the **levorotatory isomer** of **tetramisole**, this statement describes its chemical structure, not its primary clinical use. - **Tetramisole** itself exists as a **racemic mixture** of both levo and dextro isomers. *It has immunomodulator action* - **Levamisole** does possess **immunomodulatory properties** at lower doses and was historically investigated for conditions like **rheumatoid arthritis** and as an adjuvant in colon cancer. - However, its primary and most widespread clinical use is as an **anthelmintic**, not as an immunomodulator, especially due to concerns about side effects like **agranulocytosis**. *It can kill strongyloides larvae and adult worms* - **Levamisole** is **not effective** against **Strongyloides stercoralis** (threadworms). - The drug of choice for **strongyloidiasis** is typically **ivermectin** or **albendazole**.

Q: What is the approximate incidence of hepatotoxicity in patients receiving HAART?

10%. ***10%*** - The incidence of **hepatotoxicity** among patients on **HAART** (Highly Active Antiretroviral Therapy) is estimated to be around 10%. - This adverse effect can range from mild, asymptomatic enzyme elevations to **severe liver injury**. *20%* - While hepatotoxicity is a known complication of HAART, an incidence of 20% is generally considered higher than the average reported rates in most studies. - Higher rates might be encountered in specific high-risk populations, such as those with pre-existing liver disease or co-infection with viral hepatitis, but not as a general approximation. *30%* - An incidence of 30% for HAART-induced hepatotoxicity is significantly higher than typically observed and would suggest a higher level of risk than is generally presented in clinical literature. - Such high rates are usually associated with specific, older regimens or very vulnerable patient groups. *40%* - An incidence of 40% is exceptionally high for HAART-induced hepatotoxicity and would indicate a severe and frequent adverse reaction, which is not characteristic of modern HAART regimens. - This figure is not representative of the general incidence in patients receiving contemporary antiretroviral therapy.

Q: For systemic mycosis, fluconazole is preferred over ketoconazole because of:

All of the options. ***All of the options*** Fluconazole is preferred over ketoconazole for systemic mycoses due to multiple superior pharmacological properties: **Greater Efficacy:** - Fluconazole has **excellent bioavailability** (>90% oral) and superior tissue penetration, especially into the CNS and CSF - Highly effective against **Candida species** (including systemic candidiasis) and **Cryptococcus neoformans** (cryptococcal meningitis) - Ketoconazole has poor CNS penetration, making it unsuitable for deep-seated infections **Longer Half-life (t1/2):** - Fluconazole has a **half-life of ~30 hours**, enabling **once-daily dosing** - Ketoconazole has a half-life of ~8 hours, requiring multiple daily doses - Longer half-life improves patient compliance and maintains therapeutic drug levels **Lesser Side Effects:** - Fluconazole has **minimal hepatotoxicity** and is generally well-tolerated - Ketoconazole causes **significant hepatotoxicity** (black box warning) and **endocrine disturbances** by blocking steroid synthesis (gynecomastia, decreased testosterone, adrenal suppression) - Fluconazole does not interfere with steroid hormone synthesis at therapeutic doses **Clinical Practice:** Due to these combined advantages, ketoconazole is now rarely used for systemic mycoses and is primarily reserved for topical applications or specific resistant dermatophyte infections.

Q: Mechanism of action of Linezolid is

Inhibits peptide bond formation. ***Inhibits peptide bond formation*** - Linezolid is an **oxazolidinone antibiotic** that acts at the **initiation stage of bacterial protein synthesis**. - It binds to the **23S ribosomal RNA** of the 50S subunit, preventing formation of the **70S initiation complex** and thereby **blocking the formation of the first peptide bond**. - This is the **functional mechanism** that defines its antibacterial action. *Inhibits 30S ribosomal subunit* - This mechanism is characteristic of **aminoglycosides** (e.g., gentamicin) and **tetracyclines**, which target the 30S ribosomal subunit. - Linezolid specifically targets the **50S subunit**, not the 30S subunit. *Inhibits 23S ribosome subunit of 50S ribosome* - While this correctly describes Linezolid's **binding site** (23S rRNA of the 50S subunit), it does not specify the **functional consequence** of this binding. - The **mechanism of action** in pharmacology refers to the functional effect, which is **inhibition of peptide bond formation** at the initiation stage. - This option describes "where" the drug acts rather than "what" it does at that site. *Inhibits tRNA translocation on the ribosome* - This is the mechanism of **macrolides** (e.g., erythromycin, azithromycin) and **chloramphenicol**, which block the translocation of peptidyl-tRNA from the A-site to the P-site. - Linezolid acts at the **initiation phase**, not during elongation/translocation.

Q: Which of the following is a topical antifungal agent?

Butenafine. ***Butenafine*** - **Butenafine** belongs to the class of **benzylamine antifungals** and is used topically to treat fungal infections such as **tinea pedis (athlete's foot)**, **tinea cruris (jock itch)**, and **tinea corporis (ringworm)**. - Its mechanism of action involves inhibiting **squalene epoxidase**, an enzyme essential for fungal cell membrane synthesis, leading to **ergosterol depletion** and accumulation of squalene, which is toxic to the fungus. *Benzyl benzoate* - **Benzyl benzoate** is primarily used as a **topical scabicide** and **pediculicide**, meaning it targets mites (scabies) and lice. - It works by acting as a **neurotoxin** to these parasites, causing paralysis and death, and is not classified as an antifungal agent. *Brimetenide* - This option appears to be a **misspelling** or **non-existent drug name** in common pharmaceutical contexts. - There is no widely recognized drug with the name **"Brimetenide"** that serves as an antifungal. *Posaconazole* - **Posaconazole** is a **systemic triazole antifungal**, typically administered orally or intravenously for the treatment and prophylaxis of invasive fungal infections in immunocompromised patients. - While it is an antifungal, its primary use is **systemic** rather than topical for treating superficial dermatophyte infections.

Q: Which macrolide is MOST active against Mycobacterium leprae?

Clarithromycin. **Correct: Clarithromycin** - **Clarithromycin** is the most active macrolide against **Mycobacterium leprae**, with significant in-vitro and in-vivo bactericidal activity - It is a preferred macrolide for leprosy treatment, particularly useful as an alternative in multidrug therapy (MDT) regimens - Its efficacy is attributed to its ability to attain **high intracellular concentrations** and effectively inhibit mycobacterial protein synthesis - Superior to other macrolides in terms of potency against *M. leprae* *Incorrect: Azithromycin* - While **azithromycin** possesses some activity against *M. leprae*, its potency is **less than clarithromycin** - It has a longer half-life and good tissue penetration, but is not the most active macrolide for this indication - Sometimes used in leprosy regimens, but not typically cited as the most active macrolide *Incorrect: Roxithromycin* - **Roxithromycin** has demonstrated some activity against *M. leprae* in laboratory settings, but is **not as extensively studied or commonly used** as clarithromycin for leprosy - Its clinical utility for leprosy is less well-established - Not considered first-line among macrolides for this indication *Incorrect: Erythromycin* - **Erythromycin**, the first macrolide discovered, has **limited activity** against *M. leprae* compared to newer macrolides like clarithromycin - Poor bioavailability and more frequent dosing requirements make it less practical - Not considered a primary agent for the treatment of leprosy

Question 1

What is a known side effect of clofazimine?

Accepted Answer

Reddish black skin discoloration

Answer

Hemolytic anaemia

Answer

Flu like syndrome

Answer

Axillary freckling

Question 2

Which of the following causes retinal pigmentation?

Accepted Answer

Chloroquine

Answer

Quinine

Answer

Mefloquine

Answer

Atovaquone

Question 3

Which of the following statements about the primary clinical use of levamisole is true?

Accepted Answer

It is used against ascariasis and ancyclostomiasis

Answer

It has immunomodulator action

Answer

It is the levoisomer of tetramisole

Answer

It can kill strongyloides larvae and adult worms

Question 4

What is the approximate incidence of hepatotoxicity in patients receiving HAART?

Accepted Answer

10%

Answer

20%

Answer

30%

Answer

40%

Question 5

For systemic mycosis, fluconazole is preferred over ketoconazole because of:

Accepted Answer

All of the options

Answer

Lesser side effects

Answer

Greater efficacy

Answer

Longer t1/2

Question 6

Mechanism of action of Linezolid is

Accepted Answer

Inhibits peptide bond formation

Answer

Inhibits 30S ribosomal subunit

Answer

Inhibits 23S ribosome subunit of 50S ribosome

Answer

Inhibits tRNA translocation on the ribosome

Question 7

Which of the following is a topical antifungal agent?

Accepted Answer

Butenafine

Answer

Benzyl benzoate

Answer

Brimetenide

Answer

Posaconazole

Question 8

Ivermectin is the drug of choice for which of the following infections?

Accepted Answer

Onchocerciasis (river blindness caused by Onchocerca volvulus)

Answer

Trichuriasis (whipworm infection)

Answer

Loiasis (African eye worm)

Answer

Trichinosis (pork roundworm infection)

Question 9

Which of the following drugs has the highest nephrotoxic potential and requires the most careful monitoring in patients with renal failure?

Accepted Answer

Gentamicin

Answer

Ciprofloxacin

Answer

Vancomycin

Answer

Ampicillin

Question 10

Which macrolide is MOST active against Mycobacterium leprae?

Accepted Answer

Clarithromycin

Answer

Erythromycin

Answer

Azithromycin

Answer

Roxithromycin

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?